Distribution of NHL Cases by the Consensus Diagnosis
Consensus Diagnosis . | No. of Cases . | % of Total Cases . |
---|---|---|
Diffuse large B-cell | 422 | 30.6 |
Follicular | 304 | 22.1 |
Grade 1 | 131 | 9.5 |
Grade 2 | 85 | 6.2 |
Grade 3 | 88 | 6.4 |
Marginal zone B-cell, MALT | 105 | 7.6 |
Peripheral T-cell | 96 | 7.0 |
Medium-sized, mixed, and large | 51 | 3.7 |
Angiocentric, nasal | 19 | 1.4 |
Angioimmunoblastic | 17 | 1.2 |
Intestinal | 5 | <1 |
Lymphoepithelioid | 2 | <1 |
Hepatosplenic | 1 | <1 |
Adult T-cell leukemia/lymphoma | 1 | <1 |
Small B-lymphocytic (CLL) | 93 | 6.7 |
Mantle cell | 83 | 6.0 |
Primary mediastinal large B-cell | 33 | 2.4 |
Anaplastic large T/null-cell | 33 | 2.4 |
High grade B-cell, Burkitt-like | 29 | 2.1 |
Marginal zone B-cell, nodal | 25 | 1.8 |
Precursor T-lymphoblastic | 23 | 1.7 |
Lymphoplasmacytoid | 16 | 1.2 |
Marginal zone B-cell, splenic | 11 | <1 |
Mycosis fungoides | 11 | <1 |
Burkitt's | 10 | <1 |
All other types | 84 | 6.1 |
Consensus Diagnosis . | No. of Cases . | % of Total Cases . |
---|---|---|
Diffuse large B-cell | 422 | 30.6 |
Follicular | 304 | 22.1 |
Grade 1 | 131 | 9.5 |
Grade 2 | 85 | 6.2 |
Grade 3 | 88 | 6.4 |
Marginal zone B-cell, MALT | 105 | 7.6 |
Peripheral T-cell | 96 | 7.0 |
Medium-sized, mixed, and large | 51 | 3.7 |
Angiocentric, nasal | 19 | 1.4 |
Angioimmunoblastic | 17 | 1.2 |
Intestinal | 5 | <1 |
Lymphoepithelioid | 2 | <1 |
Hepatosplenic | 1 | <1 |
Adult T-cell leukemia/lymphoma | 1 | <1 |
Small B-lymphocytic (CLL) | 93 | 6.7 |
Mantle cell | 83 | 6.0 |
Primary mediastinal large B-cell | 33 | 2.4 |
Anaplastic large T/null-cell | 33 | 2.4 |
High grade B-cell, Burkitt-like | 29 | 2.1 |
Marginal zone B-cell, nodal | 25 | 1.8 |
Precursor T-lymphoblastic | 23 | 1.7 |
Lymphoplasmacytoid | 16 | 1.2 |
Marginal zone B-cell, splenic | 11 | <1 |
Mycosis fungoides | 11 | <1 |
Burkitt's | 10 | <1 |
All other types | 84 | 6.1 |
Abbreviation: CLL, chronic lymphocytic leukemia.